{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T08:01:16Z","timestamp":1713340876174},"reference-count":35,"publisher":"Springer Publishing Company","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p>Gestational substance exposure continues to be a significant problem. Neonates may be exposed to various substances including illicit drugs, prescription drugs, and other legal substances that are best not used during pregnancy because of their potential deleterious effects as possible teratogens or their potential to create dependence and thus withdrawal in the neonate. Screening the newborn for gestational substance exposure is important for both acute care and early intervention to promote the best possible long-term outcomes. This column provides insight into what is known about the extent of substance use by pregnant women, an overview of neonatal biologic matrices for drug testing, and a discussion of the legal implications of neonatal substance screening.<\/jats:p>","DOI":"10.1891\/0730-0832.35.5.321","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T03:04:10Z","timestamp":1473995050000},"page":"321-326","source":"Crossref","is-referenced-by-count":4,"title":["Drug Screening in Neonates"],"prefix":"10.1891","volume":"35","author":[{"given":"Susan Givens","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"2019091815151565000_35.5.321.1","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014."},{"key":"2019091815151565000_35.5.321.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2013.05.017"},{"key":"2019091815151565000_35.5.321.3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000208"},{"key":"2019091815151565000_35.5.321.4","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000172"},{"key":"2019091815151565000_35.5.321.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2012.06.008"},{"key":"2019091815151565000_35.5.321.6","doi-asserted-by":"publisher","DOI":"10.1542\/neo4-9-e228"},{"key":"2019091815151565000_35.5.321.7","doi-asserted-by":"publisher","DOI":"10.1542\/neo.4-9-e236"},{"key":"2019091815151565000_35.5.321.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3212"},{"key":"2019091815151565000_35.5.321.9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100506"},{"key":"2019091815151565000_35.5.321.10","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/33.3.148"},{"key":"2019091815151565000_35.5.321.11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211416"},{"key":"2019091815151565000_35.5.321.12","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2008.97"},{"key":"2019091815151565000_35.5.321.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-007-1228-9"},{"key":"2019091815151565000_35.5.321.14","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31828a6148"},{"issue":"4","key":"2019091815151565000_35.5.321.15","first-page":"301","article-title":"Rational use and interpretation of urine drug testing in chronic opioid therapy","volume":"37","year":"2007","journal-title":"Ann Clin Lab Sci"},{"key":"2019091815151565000_35.5.321.16","unstructured":"American Society of Addiction Medicine. Drug testing: a white paper of the American Society of Addiction Medicine (ASAM). October 26, 2013. American Society of Addiction Medicine website. http:\/\/www.asam.org\/docs\/default-source\/public-policy-statements\/drug-testing-a-white-paper-by-asam.pdf. Accessed April 27, 2016."},{"issue":"2","key":"2019091815151565000_35.5.321.17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/55.2.326","article-title":"Rayon balls and disposable-diaper material selectively absorb creatinine","volume":"55","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"2019091815151565000_35.5.321.18","unstructured":"United States Drug Testing Laboratory. Meconium testing for newborn drug & alcohol exposure. United States Drug Testing Laboratory website. http:\/\/www.usdtl.com\/testing\/meconium-drug-test-labs. Accessed April 7, 2016."},{"key":"2019091815151565000_35.5.321.19","unstructured":"ARUP Laboratories. Drugs of abuse panel, meconium\u2014screen with reflex to confirmation\/quantitation. http:\/\/ltd.aruplab.com\/Tests\/Pub\/0092516. Accessed May 4, 2016."},{"key":"2019091815151565000_35.5.321.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(55)80205-3"},{"key":"2019091815151565000_35.5.321.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83550-4"},{"key":"2019091815151565000_35.5.321.22","unstructured":"Hamdan AH . Neonatal abstinence syndrome. Medscape website. http:\/\/emedicine.medscape.com\/article\/978763-overview. Published January 2, 2016. Accessed May 4, 2016."},{"key":"2019091815151565000_35.5.321.23","unstructured":"United States Drug Testing Laboratory. Umbilical cord drug testing. United States Drug Testing Laboratory website. http:\/\/www.usdtl.com\/testing\/umbilical-cord-tissue-drug-test-labs. Accessed April 8, 2016."},{"key":"2019091815151565000_35.5.321.24","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815c14ce"},{"key":"2019091815151565000_35.5.321.25","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.2.F98"},{"key":"2019091815151565000_35.5.321.26","doi-asserted-by":"publisher","DOI":"10.4155\/BIO.15.60"},{"key":"2019091815151565000_35.5.321.27","unstructured":"United States National Library of Medicine. LactMed: a new NLM database on drugs and lactation. https:\/\/www.nlm.nih.gov\/news\/lactmed_announce_06.html. Accessed May 6, 2016."},{"key":"2019091815151565000_35.5.321.28","unstructured":"Quest Diagnostics. Drug abuse screen, breast milk [19523X]. Quest Diagnostics website. http:\/\/www.questdiagnostics.com\/testcenter\/BUOrderInfo.action?tc=2287101&labCode=AMD. Accessed April 8, 2016."},{"key":"2019091815151565000_35.5.321.29","unstructured":"United States Drug Testing Laboratory. Breast milk drug testing. United States Drug Testing Laboratory website. http:\/\/www.usdtl.com\/testing\/breast-milk-drug-test-labs. Accessed April 8, 2016."},{"key":"2019091815151565000_35.5.321.30","unstructured":"Child Welfare Information Gateway. Parental drug use as child abuse. https:\/\/www.childwelfare.gov\/topics\/systemwide\/laws-policies\/statutes\/drugexposed\/. Accessed April 9, 2016."},{"key":"2019091815151565000_35.5.321.31","unstructured":"U.S. Department of Health and Human Services. The Child Abuse Prevention and Treatment Act (as amended by P.L. 111-320 The CAPTA Restoration Act of 2010). Administration for Children & Families website. http:\/\/www.acf.hhs.gov\/sites\/default\/files\/cb\/capta2010.pdf. Accessed April 9, 2016."},{"key":"2019091815151565000_35.5.321.32","unstructured":"Quest Diagnostics. Employer drug testing solutions. Quest Diagnostics website. http:\/\/www.questdiagnostics.com\/dms\/Documents\/Employer-Solutions\/Brochures\/quest-complete-line-drug-testing-solutions-15\/quest-complete-line-drug-testing-solutions-2016.pdf. Accessed May 6, 2016."},{"key":"2019091815151565000_35.5.321.33","unstructured":"State marijuana laws map. Governing website. http:\/\/www.governing.com\/gov-data\/state-marijuana-laws-map-medical-recreational.html. Accessed May 6, 2016."},{"key":"2019091815151565000_35.5.321.34","unstructured":"American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Committee Opinion No. 637: marijuana use during pregnancy and lactation. American College of Obstetricians and Gynecologists website. https:\/\/www.acog.org\/-\/media\/Committee-Opinions\/Committee-on-Obstetric-Practice\/co637.pdf?dmc=1&ts=20160506T1648326457. Accessed May 6, 2016."},{"key":"2019091815151565000_35.5.321.35","unstructured":"Colorado Department of Public Health and Environment. Marijuana pregnancy and breastfeeding guidance for Colorado health providers. Colorado State website. https:\/\/www.colorado.gov\/pacific\/sites\/default\/files\/MJ_RMEP_Pregnancy-Breastfeeding-Clinical-Guidelines.pdf. Accessed May 6, 2016."}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/0730-0832.35.5.321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T22:15:39Z","timestamp":1568844939000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/0730-0832.35.5.321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,1,1]]},"published-print":{"date-parts":[[2016]]}},"alternative-id":["10.1891\/0730-0832.35.5.321"],"URL":"https:\/\/doi.org\/10.1891\/0730-0832.35.5.321","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}